- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05782088
Single Versus Repeated Piezocision-assisted Orthodontic Tooth Movement
March 24, 2024 updated by: Nourhan M.Aly
Single Versus Repeated Piezocision-assisted Orthodontic Tooth Movement: a Randomized Controlled Clinical Trial
The primary aim of the study is to evaluate the effect of single and repeated piezocisions on the rate of orthodontic tooth movement.
Secondary aims are to evaluate the effect of both protocols on molar anchorage loss, as well as on canine root resorption.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alexandria, Egypt, 21512
- Faculty of dentistry, Alexandria university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Malocclusion that requires at least the extraction of maxillary first premolars, such as Class I bimaxillary protrusion, and Class II division 1 cases.
- Normal shape and structure of the maxillary canines, with no history of root canal treatment
Exclusion Criteria:
- Patients who underwent previous orthodontic treatment.
- Patients currently receiving drug therapy that may affect orthodontic tooth movement, e.g. hormonal therapy and corticosteroids.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single Piezocision
|
Piezocision will be performed only once before the onset of canine retraction (T0) on one side of the maxillary arch that will be randomly chosen.
|
|
Experimental: Repeated Piezocision
|
Piezocision will be repeated three times, on a monthly basis (T0, T1, and T2), over the 12-week study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of canine retraction
Time Frame: 12 weeks
|
Several landmarks will be identified on the dental arch, including the mid-palatal raphe, the most medial points on the third right and left rugae, and the cusp tips of the right and left maxillary canines.
Perpendicular lines will be drawn from the medial points of the right and left third rugae, and the cusp tips of the right and left maxillary canines to the mid-palatal raphe.
The antero-posterior measurements will be carried out between the canine lines and the third rugae lines bilaterally, to assess the rate of canine retraction.
|
12 weeks
|
|
Measurement of molar anchorage loss
Time Frame: 12 weeks
|
Perpendicular lines will be drawn from the central fossae of both maxillary right and left first molars to the mid-palatal raphe.
Consequently, molar anchorage loss will be calculated by measuring the distance between those lines, and the lines representing the third rugae as previously mentioned.
|
12 weeks
|
|
Measurement of canine root resorption
Time Frame: 12 weeks
|
Root resorption of the maxillary canines will be evaluated and measured by comparing pre-retraction and post-retraction CBCT scans.
|
12 weeks
|
|
Bone Microstructure (Fractal Dimension)
Time Frame: 12 weeks
|
Using the collected CBCT scans, the region of interest will be selected within the maxillary alveolar process, and the fractal dimension analysis will be performed using a special software for the maxillary canines in the experimental and control groups.
|
12 weeks
|
|
Alveolar bone density
Time Frame: 12 weeks
|
From the acquired pre- and post-retraction CBCTs, bone density will be measured form a coronal cross-section of the maxillary arch around each canine in the experimental and control groups.
|
12 weeks
|
|
Alveolar bone thickness
Time Frame: 12 weeks
|
The buccal bone thickness will also be measured at three points from the buccal bone to the root, at the coronal, mid-root, and apical level for each maxillary canine
|
12 weeks
|
|
Alveolar bone volume
Time Frame: 12 weeks
|
From the pre- and post-retraction CBCTs (at T0 and T1), bone volume in areas of the maxillary alveolar process surrounding the canines will be measured using a special software.
|
12 weeks
|
|
Maxillary canine tipping
Time Frame: 12 weeks
|
Tipping of the maxillary canine during retraction was evaluated by drawing vertical lines on the palatal surfaces of the lateral incisor and the canine that extend from the middle of the incisal edge of the lateral incisor and the cusp tip of the maxillary canine to the middle of the cervical line of each, thereby dividing each of them into equal halves.
The distance between the lateral incisor and the canine was assessed at two points on their clinical crowns: incisal, and cervical, enabling the detection of crown tipping of the canine during retraction if there was a difference in the measurements between the both the assessed levels.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Farah Y Eid, PhD, Alexandria University
- Study Director: Ahmed R El-Kalza, PhD, Alexandria University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Actual)
January 1, 2024
Study Completion (Actual)
January 15, 2024
Study Registration Dates
First Submitted
March 12, 2023
First Submitted That Met QC Criteria
March 12, 2023
First Posted (Actual)
March 23, 2023
Study Record Updates
Last Update Posted (Actual)
March 26, 2024
Last Update Submitted That Met QC Criteria
March 24, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 200
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.